Federal Register Notice: FDA is making available a draft guidance for industry, Presenting Risk Information in Prescription Drug and Medical Device Promotion. It responds to stakeholder requests for specific guidance on how the agency evaluates prescription drug and device promotional pieces to determine whether they adequately present risk information. To download this guidance, click here. To view this notice, click here.
